Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer.

Li H, Guo L, Chen SW, Zhao XH, Zhuang SM, Wang LP, Song LB, Song M.

J Transl Med. 2012 Aug 20;10:168. doi: 10.1186/1479-5876-10-168.

2.

Golgi phosphoprotein3 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.

Jiang Y, Su Y, Zhao Y, Pan C, Chen L.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10615-24. eCollection 2015. Review.

3.

GOLPH3 links the Golgi, DNA damage, and cancer.

Buschman MD, Rahajeng J, Field SJ.

Cancer Res. 2015 Feb 15;75(4):624-7. doi: 10.1158/0008-5472.CAN-14-3081. Epub 2015 Jan 29. Review.

4.

The GOLPH3 pathway regulates Golgi shape and function and is activated by DNA damage.

Buschman MD, Xing M, Field SJ.

Front Neurosci. 2015 Oct 7;9:362. doi: 10.3389/fnins.2015.00362. eCollection 2015. Review.

5.

Proteomics Identifies Golgi phosphoprotein 3 (GOLPH3) with A Link Between Golgi Structure, Cancer, DNA Damage and Protection from Cell Death.

Bergeron JJM, Au CE, Thomas DY, Hermo L.

Mol Cell Proteomics. 2017 Dec;16(12):2048-2054. doi: 10.1074/mcp.MR117.000068. Epub 2017 Sep 27. Review.

PMID:
28954815
6.

Mechanisms correlated with chemotherapy resistance in tongue cancers.

Han G, Xu C, Yu D.

J Cancer Res Ther. 2018 Jan;14(1):1-5. doi: 10.4103/jcrt.JCRT_763_17. Review.

Supplemental Content

Support Center